Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from iX Biopharma Ltd. ( (SG:42C) ).
iX Biopharma Ltd. held an Extraordinary General Meeting (EGM) on March 10, 2025, chaired by Mr. Eddy Lee Yip Hang. The meeting included the Board of Directors and shareholders, with voting conducted by poll. The meeting proceeded without any questions from shareholders, and all motions were proposed by the Chairman.
More about iX Biopharma Ltd.
iX Biopharma Ltd. is a company incorporated in Singapore, operating within the biopharmaceutical industry. The company focuses on developing and commercializing innovative therapies and products, leveraging its proprietary sublingual drug delivery technology.
YTD Price Performance: 5.00%
Average Trading Volume: 298,678
Technical Sentiment Signal: Buy
Current Market Cap: S$18.59M
See more data about 42C stock on TipRanks’ Stock Analysis page.
Trending Articles:
- “…Overlook a Lack of Earnings Power”: UBS Analysts Target Intel Stock (NASDAQ:INTC), Stock Gains
- “…Significantly Extend the Reach and Lethality of our Fleet”: Boeing Stock (NYSE:BA) Slips Despite Successful MQ-25A Test
- “Direct Result of Your Feedback….” Microsoft Stock (NASDAQ:MSFT) Slips as The Option to Skip Updates Emerges